1 / 23

Department of Pharmacology

Section 4 Drugs Affecting the Center Nervous System. Department of Pharmacology. Chapter 22 Sedative and hypnotic Drugs. Definitions A sedative drug decreases activity, moderates excitement, and calms the recipient.

bonnie
Télécharger la présentation

Department of Pharmacology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Section 4 Drugs Affecting the Center Nervous System Department of Pharmacology

  2. Chapter 22 Sedative and hypnotic Drugs

  3. Definitions • A sedative drug decreases activity, moderates excitement, and calms the recipient. • A hypnotic drug produces drowsiness and facilitates the onset and maintenance of a state of sleep that resembles natural sleep, and from which the patient can be easily aroused.

  4. Drugs: • Benzodiazepines (BDZs) • Barbiturates • Others: chloral hydrate • Small dose: sedation • Large dose: hypnosis;anticonvulsant; anesthesia

  5. 苯二氮卓类 (Benzodiazepines BZ) 地西泮（安定） Diazepam 奥沙西泮 Oxazepam 三唑仑 Triazolam

  6. Drugs Elimination half life (hours) Dosage（mg） sedative hypnotic Diazepam 30~60 2.5~5 ,tid 5~10 Oxazepam 5~10 15~30, qd,tid 15~30 Triazolam 1.5~3 - 0.25~0.5（15~30分起效)

  7. Diazepam 地西泮 • （valium, 安定） • Action and use: • Reduction of anxiety The anxiolytic actions can be occurred at lower dosage . lose memory, Preanesthetic medication • Sedative and hypnosis mainly prolong stage 2 of NREMS, shorten REMS and latency of sleep onset

  8. Stages of Sleep When subject falls asleep, EEG progresses through stages: • non-rapid-eye movement sleep, NREMS including 1、2、3、4 stages ，stage 3、4 also called “ Slow wave sleep，SWS” （慢波睡眠） • rapid eye movement sleep, REMS

  9. SLEEP: NREMS REMS NREMS REMS：NS development，memory NREMS： 1,2 stages 3,4 stages (Slow wave sleep，SWS) growth ,restore

  10. Anticonvulsant and antiepileptic action iv diazepam is the best choice for status epilepticus (癫痫持续状态) • Central muscle relaxing treatment for central myotonia (肌强直)caused by cerebral accident(脑血管意外) or spinal cord injury(脊髓损伤)

  11. Mechanism: Promote GABA receptor function • γ- butylamino acid, GABA • GABA A receptor consists of twoα1,two β2 and one γ2 subunits. • GABA A receptor, which functions as a chloride ion channel, is activated by the inhibitory neurotransmitter GABA .

  12. GABA appears to interact with αorβsubunits triggering chloride channel opening with resultant membrane hyperpolarization. • The binding site for BDZs (BDZ-receptor) is located between αandγsubunit.

  13. BDZs appear to increase the efficiency of GABAergic synaptic inhibition. • The enhancement in chloride ion conductance induced by the interaction of BDZs with GABA takes the form of an increase in the frequency of channel-opening events.

  14. Side effects: • common: hypersomnia, drowsiness, ataxia, impaired judgment, diminished motor skills. • iv too fast cause CNS depression • rarely fatal even following very high doses. Except: the presence of other central nervous system depressants; child, elder patients；patients with severe liver disease

  15. Treatment of toxicosis: • Ensuring the living symptom • Maintenance of plasma volume, renal output, cardiac function • purging the stomach；Hemodialysis • BDZreceptor antagonist flumazenil (氟马西尼,安易行） • Tolerance and addiction • Fetal deformation

  16. Barbiturates Classification: Drug t½(h)onset duration (h) Phenobarbital 24-140 + 6-8 (luminal,苯巴比妥) Amobarbital 8-42 ++ 3-6 (amytal,异戊巴比妥) Secobarbital（司可巴比妥）19-34 +++ 2-3 Thiopental（硫喷妥 ）3-8 ++++ 1-4

  17. Action and use: • sedative and hypnosis • shorten REMS • dose dependence • anticonvulsant(phenobarbital) • anesthesia and preanestheticmedication (thiopental) • enhance CNS depression

  18. Mechanism • It can activate GABAA receptor, potentiate GABA action on chloride entry into the neuron. • Barbiturates: increase the open timeofCl-channel • BZ: increase the open frequencyofCl- channel

  19. Adverse effect • drug hangover: tiredness after awakes • tolerance: induce P-450 system • addiction: abrupt withdrawal may cause • tremor, anxiety, weakness, restlessness, • nausea and vomiting • respiratory depression • allergy

  20. Poisoning Poisoning: overdoses can cause death, depression of respiration and central cardiovascular depression. Treatment: artificial respiration; purging the stomach of its contents; alkalinization of blood and urine; hemodialysis

  21. BDZ’s ADVANTAGE: • therapeutic index high, safe range broad • no inductive effects on P-450 system, less tolerance • less effects on REMS, dependence, withdraw syndrome slight • side effects mild • BZreceptor antagonist —— flumazenil 氟马西尼

  22. Other sedatives Chloral hydrate水合氯醛 induces sleep in about 15 minutes and lasts 6~8 hours. irritates to the gastrointestinal tract and causes epigastric distress, also produces an unusual, unpleasant taste sensation.

  23. Central stimulants • Stimulating cerebral cortex: Caffeine 咖啡因 Theophylline 茶碱 • Stimulating medullary respiratory center 延髓呼吸中枢 Nikethamide 尼可刹米 Lobeline 洛贝林

More Related